Aggressive digital papillary adenocarcinoma: a review

Summary Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental dermatology 2010-03, Vol.35 (2), p.113-119
Hauptverfasser: Hsu, H.-C., Ho, C.-Y., Chen, C.-H., Yang, C.-H., Hong, H.-S., Chuang, Y.-H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 119
container_issue 2
container_start_page 113
container_title Clinical and experimental dermatology
container_volume 35
creator Hsu, H.-C.
Ho, C.-Y.
Chen, C.-H.
Yang, C.-H.
Hong, H.-S.
Chuang, Y.-H.
description Summary Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.
doi_str_mv 10.1111/j.1365-2230.2009.03490.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733955244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733955244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</originalsourceid><addsrcrecordid>eNqNkF1v0zAUhi0EYmXwF1AkhLhK8NeJbSQuRtnGxwAhhri0HOekckmTYrdb9-9xaFUkrvCNLfl5fV4_hBSMViyvl8uKiRpKzgWtOKWmokIaWu3ukdnx4j6ZUUFVWRuhT8ijlJaUMsEUPCQnzGglBYcZgbPFImJK4QaLNizCxvXF2q1D37t4V7gWh9G76MMwrtyrwhURbwLePiYPOtcnfHLYT8n3i_Pr-bvy6svl-_nZVemBSVo6DUoq6KjxTjChFKu5RupECw5BYaNq33UaTQONpxrBmEZwAVzXbU1RiVPyYv_uOo6_tpg2dhWSx1xuwHGbrBLCAHApM_nsH3I5buOQy1kGEjTjxkyU3lM-jilF7Ow6hlX-qWXUTmbt0k4C7STQTmbtH7N2l6NPDwO2zQrbv8GDygw8PwAuedd30Q0-pCPHuaTGcJO513vuNvR4998F7Pz87XTK-XKfD2mDu2PexZ-2VkKB_fH50n6VF9cfP314Y7-J3-h2oNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1545812994</pqid></control><display><type>article</type><title>Aggressive digital papillary adenocarcinoma: a review</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Hsu, H.-C. ; Ho, C.-Y. ; Chen, C.-H. ; Yang, C.-H. ; Hong, H.-S. ; Chuang, Y.-H.</creator><creatorcontrib>Hsu, H.-C. ; Ho, C.-Y. ; Chen, C.-H. ; Yang, C.-H. ; Hong, H.-S. ; Chuang, Y.-H.</creatorcontrib><description>Summary Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.</description><identifier>ISSN: 0307-6938</identifier><identifier>EISSN: 1365-2230</identifier><identifier>DOI: 10.1111/j.1365-2230.2009.03490.x</identifier><identifier>PMID: 19874325</identifier><identifier>CODEN: CEDEDE</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenocarcinoma, Papillary - pathology ; Adenocarcinoma, Papillary - surgery ; Amputation ; Biological and medical sciences ; Dermatology ; Fingers - surgery ; Humans ; Medical sciences ; Skin Neoplasms - pathology ; Skin Neoplasms - surgery ; Time Factors ; Toes - surgery</subject><ispartof>Clinical and experimental dermatology, 2010-03, Vol.35 (2), p.113-119</ispartof><rights>2009 The Author(s). Journal compilation © 2009 British Association of Dermatologists</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</citedby><cites>FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22409929$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19874325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hsu, H.-C.</creatorcontrib><creatorcontrib>Ho, C.-Y.</creatorcontrib><creatorcontrib>Chen, C.-H.</creatorcontrib><creatorcontrib>Yang, C.-H.</creatorcontrib><creatorcontrib>Hong, H.-S.</creatorcontrib><creatorcontrib>Chuang, Y.-H.</creatorcontrib><title>Aggressive digital papillary adenocarcinoma: a review</title><title>Clinical and experimental dermatology</title><addtitle>Clin Exp Dermatol</addtitle><description>Summary Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.</description><subject>Adenocarcinoma, Papillary - pathology</subject><subject>Adenocarcinoma, Papillary - surgery</subject><subject>Amputation</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>Fingers - surgery</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Skin Neoplasms - pathology</subject><subject>Skin Neoplasms - surgery</subject><subject>Time Factors</subject><subject>Toes - surgery</subject><issn>0307-6938</issn><issn>1365-2230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1v0zAUhi0EYmXwF1AkhLhK8NeJbSQuRtnGxwAhhri0HOekckmTYrdb9-9xaFUkrvCNLfl5fV4_hBSMViyvl8uKiRpKzgWtOKWmokIaWu3ukdnx4j6ZUUFVWRuhT8ijlJaUMsEUPCQnzGglBYcZgbPFImJK4QaLNizCxvXF2q1D37t4V7gWh9G76MMwrtyrwhURbwLePiYPOtcnfHLYT8n3i_Pr-bvy6svl-_nZVemBSVo6DUoq6KjxTjChFKu5RupECw5BYaNq33UaTQONpxrBmEZwAVzXbU1RiVPyYv_uOo6_tpg2dhWSx1xuwHGbrBLCAHApM_nsH3I5buOQy1kGEjTjxkyU3lM-jilF7Ow6hlX-qWXUTmbt0k4C7STQTmbtH7N2l6NPDwO2zQrbv8GDygw8PwAuedd30Q0-pCPHuaTGcJO513vuNvR4998F7Pz87XTK-XKfD2mDu2PexZ-2VkKB_fH50n6VF9cfP314Y7-J3-h2oNA</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Hsu, H.-C.</creator><creator>Ho, C.-Y.</creator><creator>Chen, C.-H.</creator><creator>Yang, C.-H.</creator><creator>Hong, H.-S.</creator><creator>Chuang, Y.-H.</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201003</creationdate><title>Aggressive digital papillary adenocarcinoma: a review</title><author>Hsu, H.-C. ; Ho, C.-Y. ; Chen, C.-H. ; Yang, C.-H. ; Hong, H.-S. ; Chuang, Y.-H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5140-a857475f09ca313771628e0a3d5ae57eb76cff8e9b5bc08e599b3235286d60e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adenocarcinoma, Papillary - pathology</topic><topic>Adenocarcinoma, Papillary - surgery</topic><topic>Amputation</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>Fingers - surgery</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Skin Neoplasms - pathology</topic><topic>Skin Neoplasms - surgery</topic><topic>Time Factors</topic><topic>Toes - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hsu, H.-C.</creatorcontrib><creatorcontrib>Ho, C.-Y.</creatorcontrib><creatorcontrib>Chen, C.-H.</creatorcontrib><creatorcontrib>Yang, C.-H.</creatorcontrib><creatorcontrib>Hong, H.-S.</creatorcontrib><creatorcontrib>Chuang, Y.-H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hsu, H.-C.</au><au>Ho, C.-Y.</au><au>Chen, C.-H.</au><au>Yang, C.-H.</au><au>Hong, H.-S.</au><au>Chuang, Y.-H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aggressive digital papillary adenocarcinoma: a review</atitle><jtitle>Clinical and experimental dermatology</jtitle><addtitle>Clin Exp Dermatol</addtitle><date>2010-03</date><risdate>2010</risdate><volume>35</volume><issue>2</issue><spage>113</spage><epage>119</epage><pages>113-119</pages><issn>0307-6938</issn><eissn>1365-2230</eissn><coden>CEDEDE</coden><abstract>Summary Vigorous treatment of aggressive digital papillary adenocarcinoma (ADPA), including amputation, has been recommended by most authors, but the appropriateness and effectiveness of excision as an alternative to amputation has not been systematically evaluated. To evaluate the appropriateness and effectiveness of excision as an alternative to amputation in the treatment of ADPA, we reviewed the clinical presentations, treatments and patient outcomes presented in case reports on ADPA available on Ovid MEDLINE. We also assessed the results of immunohistochemical staining for proliferation markers in one patient in order to explain the nonaggressive nature of ADPA noted in that patient. Except for the duration of lesions, there was no significant difference in clinical outcome between the excision and amputation groups. We also found that p63 may be a useful marker for distinguishing primary ADPA from metastatic adenocarcinomas. In addition, the intensity of Ki67 expression in tumour cells may be a marker of aggressive behaviour and thus be helpful in therapeutic decision‐making. Wide excision with or without sentinel lymph‐node biopsy is a feasible alternative to amputation. It should be considered in patients who present with a long‐standing history of ADPA without evidence of underlying bone invasion or distant metastasis and with low‐intensity expression of proliferation markers.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19874325</pmid><doi>10.1111/j.1365-2230.2009.03490.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0307-6938
ispartof Clinical and experimental dermatology, 2010-03, Vol.35 (2), p.113-119
issn 0307-6938
1365-2230
language eng
recordid cdi_proquest_miscellaneous_733955244
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adenocarcinoma, Papillary - pathology
Adenocarcinoma, Papillary - surgery
Amputation
Biological and medical sciences
Dermatology
Fingers - surgery
Humans
Medical sciences
Skin Neoplasms - pathology
Skin Neoplasms - surgery
Time Factors
Toes - surgery
title Aggressive digital papillary adenocarcinoma: a review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T14%3A33%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aggressive%20digital%20papillary%20adenocarcinoma:%20a%20review&rft.jtitle=Clinical%20and%20experimental%20dermatology&rft.au=Hsu,%20H.-C.&rft.date=2010-03&rft.volume=35&rft.issue=2&rft.spage=113&rft.epage=119&rft.pages=113-119&rft.issn=0307-6938&rft.eissn=1365-2230&rft.coden=CEDEDE&rft_id=info:doi/10.1111/j.1365-2230.2009.03490.x&rft_dat=%3Cproquest_cross%3E733955244%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1545812994&rft_id=info:pmid/19874325&rfr_iscdi=true